Log in to save to my catalogue

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in meta...

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in meta...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1932334091

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III study

About this item

Full title

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III study

Publisher

Athens: D.A. Spandidos

Journal title

International journal of oncology, 2014-11, Vol.45 (5), p.2137-2142

Language

English

Formats

Publication information

Publisher

Athens: D.A. Spandidos

More information

Scope and Contents

Contents

We conducted a phase III multicenter randomized trial to compare the efficacy of the combination of liposome encapsulated doxorubicin (Myocet©) plus either cyclophosphamide (MC) or vinorelbine (MV). Since July 2006, 233 patients affected with metastatic breast cancer were randomized to receive the combination of Myocet (M) 60 mg/m2 i.v. plus cyclop...

Alternative Titles

Full title

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1932334091

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1932334091

Other Identifiers

ISSN

1019-6439

E-ISSN

1791-2423

DOI

10.3892/ijo.2014.2604

How to access this item